GW&K Investment Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.3M	Sell	988,387 -20,193	-2%	-$515K	0.21%	178
2025 Q4	$29.3M	Sell	1,008,580 -163,461	-14%	-$4.18M	0.25%	158
2025 Q3	$22.1M	Sell	1,172,041 -206,391	-15%	-$3.25M	0.2%	187
2025 Q2	$19.3M	Sell	1,378,432 -133,779	-9%	-$1.88M	0.17%	205
2025 Q1	$23.7M	Sell	1,512,211 -31,873	-2%	-$449K	0.22%	178
2024 Q4	$21.5M	Sell	1,544,084 -49,546	-3%	-$543K	0.18%	197
2024 Q3	$14.8M	Sell	1,593,630 -74,349	-4%	-$734K	0.13%	234
2024 Q2	$15.5M	Sell	1,667,979 -53,274	-3%	-$482K	0.14%	220
2024 Q1	$17.1M	Buy	1,721,253 +80,928	+5%	+$604K	0.15%	206
2023 Q4	$5.3M	Sell	1,640,325 -428,968	-21%	-$1.17M	0.05%	264
2023 Q3	$11M	Buy	2,069,293 +6,610	+0.3%	+$56.2K	0.11%	234
2023 Q2	$19.7M	Buy	2,062,683 +157,961	+8%	+$1.75M	0.19%	187
2023 Q1	$21M	Buy	1,904,722 +352,708	+23%	+$5.1M	0.2%	175
2022 Q4	$23M	Buy	1,552,014 +643,101	+71%	+$11.2M	0.23%	162
2022 Q3	$17.4M	Buy	908,913 +232,235	+34%	+$5.26M	0.19%	180
2022 Q2	$14.4M	Buy	676,678 +464,178	+218%	+$9.52M	0.16%	191
2022 Q1	$4.09M	Buy	+212,500	New	+$3.59M	0.04%	271